Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer

• প্রধান লেখক: Koji Harada (লেখক), Tarannum Ferdous (লেখক), Yoshiya Ueyama (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Elsevier, 2017-08-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Oral cancer has been recognized as a tumor with low sensitivity to anticancer agents. However, introduction of S-1, an oral cancer agent is improving treatment outcome for patients with oral cancer. In addition, S-1, as a main drug for oral cancer treatment in Japan can be easily available for outpa...